Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178Phase 3Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Sep 2000
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Asparaginase, dexamethasone, prednisone in acute lymphoblastic leukemia (ALL), sponsored by Dana-Farber Cancer Institute. Started Sep 2000; status: completed.
02
Drugs
Asparaginasedexamethasoneprednisone
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00165178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165178.